134 related articles for article (PubMed ID: 29905010)
1. Plasma cell-free DNA quantification is highly correlated to tumor burden in children with neuroblastoma.
Wang X; Wang L; Su Y; Yue Z; Xing T; Zhao W; Zhao Q; Duan C; Huang C; Zhang D; Jin M; Cheng X; Chen S; Liu Y; Ma X
Cancer Med; 2018 Jul; 7(7):3022-3030. PubMed ID: 29905010
[TBL] [Abstract][Full Text] [Related]
2. Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma.
Su Y; Wang L; Wang X; Yue Z; Xing T; Zhao W; Zhao Q; Duan C; Huang C; Han Y; Qiu L; Cheng X; Liu Y; Ma X
Cancer Med; 2019 Apr; 8(4):1558-1566. PubMed ID: 30793512
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma concentration of cell-free DNA precedes disease recurrence in children with high-risk neuroblastoma.
Su Y; Wang L; Jiang C; Yue Z; Fan H; Hong H; Duan C; Jin M; Zhang D; Qiu L; Cheng X; Xu Z; Ma X
BMC Cancer; 2020 Feb; 20(1):102. PubMed ID: 32028911
[TBL] [Abstract][Full Text] [Related]
4. Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.
Xu X; Yu Y; Shen M; Liu M; Wu S; Liang L; Huang F; Zhang C; Guo W; Liu T
BMC Cancer; 2020 Oct; 20(1):1006. PubMed ID: 33066758
[TBL] [Abstract][Full Text] [Related]
5. Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer.
Ren S; Zeng G; Yi Y; Liu L; Tu H; Chai T; Hu L
Heliyon; 2023 Oct; 9(10):e20851. PubMed ID: 37860559
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Analysis of Plasma Cell-Free DNA and Its DNA Integrity and Hypomethylation Status as Biomarkers for Tumor Burden and Disease Progression in Patients with Metastatic Neuroendocrine Neoplasias.
Mettler E; Fottner C; Bakhshandeh N; Trenkler A; Kuchen R; Weber MM
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205773
[TBL] [Abstract][Full Text] [Related]
7. The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients.
Wu J; Tang W; Huang L; Hou N; Wu J; Cheng X; Ma D; Qian P; Shen Q; Guo W; Peng W; Liu Y; Jiang C; Feng J
Clin Biochem; 2019 Jan; 63():59-65. PubMed ID: 30292543
[TBL] [Abstract][Full Text] [Related]
8. Serum cell-free DNA concentrations and integrity analysis of colorectal cancer patients before and after surgery.
Cao G; Xie Y; Jiang X; Tian X; Wang D; Sun Y
Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):44-51. PubMed ID: 31472046
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of cell-free DNA concentration and integrity in serum of gastric cancer patients before and after surgery.
Zhang X; Wu Z; Shen Q; Li R; Jiang X; Wu J; Li D; Wang D; Zou C; Zhong Y; Cheng X
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):111-117. PubMed ID: 31880527
[TBL] [Abstract][Full Text] [Related]
11. Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.
Man S; Yan J; Li J; Cao Y; Hu J; Ma W; Liu J; Zhao Q
Int J Med Sci; 2021; 18(8):1857-1865. PubMed ID: 33746603
[TBL] [Abstract][Full Text] [Related]
12. Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma.
Yamamoto Y; Uemura M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kinouchi T; Hayashi T; Matsuzaki K; Jingushi K; Kato T; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Nonomura N
Oncotarget; 2018 Apr; 9(29):20467-20475. PubMed ID: 29755665
[TBL] [Abstract][Full Text] [Related]
13. Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples.
Huang Y; Mu J; Qi L; Ge W; Fang X; Song Y; Yuan Y; Zheng S
Clin Chem Lab Med; 2020 Aug; 58(9):1451-1459. PubMed ID: 32229658
[TBL] [Abstract][Full Text] [Related]
14. The level and integrity of plasma circulating cell-free DNA in patients with primary multiple myeloma.
Shen Q; Cen H; Jiang J; Cong Z; Zhou Y; Huang X; Zhu L; Jiang Q; Xue C
Transl Cancer Res; 2022 Nov; 11(11):4137-4147. PubMed ID: 36523306
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
Georgantzi K; Sköldenberg EG; Stridsberg M; Kogner P; Jakobson Å; Janson ET; Christofferson RHB
Pediatr Hematol Oncol; 2018 Mar; 35(2):156-165. PubMed ID: 29737901
[TBL] [Abstract][Full Text] [Related]
16. Limited correlation between tumor markers and minimal residual disease detected by seven neuroblastoma-associated mRNAs in high-risk neuroblastoma patients.
Uemura S; Lin KS; Mon Thwin KK; Nakatani N; Ishida T; Yamamoto N; Tamura A; Saito A; Mori T; Hasegawa D; Kosaka Y; Nino N; Nagano C; Takafuji S; Iijima K; Nishimura N
Mol Clin Oncol; 2021 Jul; 15(1):137. PubMed ID: 34055352
[TBL] [Abstract][Full Text] [Related]
17. Clinical research on neuroblastoma based on serum lactate dehydrogenase.
Pang QM; Li K; Ma LJ; Sun RP
J Biol Regul Homeost Agents; 2015; 29(1):131-4. PubMed ID: 25864749
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of copy number alterations by liquid biopsy for neuroblastoma.
Shirai R; Osumi T; Sato-Otsubo A; Nakabayashi K; Ishiwata K; Yamada Y; Yoshida M; Yoshida K; Shioda Y; Kiyotani C; Terashima K; Tomizawa D; Takasugi N; Takita J; Miyazaki O; Kiyokawa N; Yoneda A; Kanamori Y; Hishiki T; Matsumoto K; Hata K; Yoshioka T; Kato M
Genes Chromosomes Cancer; 2022 Nov; 61(11):662-669. PubMed ID: 35655408
[TBL] [Abstract][Full Text] [Related]
19. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer.
Nagai Y; Sunami E; Yamamoto Y; Hata K; Okada S; Murono K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Hoon DS; Watanabe T
Oncotarget; 2017 Feb; 8(7):11906-11916. PubMed ID: 28060757
[TBL] [Abstract][Full Text] [Related]
20. A quantitative analysis of the potential biomarkers of non-small cell lung cancer by circulating cell-free DNA.
Wei L; Wu W; Han L; Yu W; Du Y
Oncol Lett; 2018 Oct; 16(4):4353-4360. PubMed ID: 30250538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
